Biotech News
News | Bavarian Nordic
December 18, 2025 | Company Announcements
Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees
December 17, 2025 | Press Releases
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
December 02, 2025 | Company Announcements
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
November 26, 2025 | Press Releases
Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen
November 14, 2025 | Company Announcements
Bavarian Nordic Announces Interim Results for the First Nine Months of 2025
November 13, 2025 | Company Announcements
Bavarian Nordic Announces Changes to the Board of Directors
November 10, 2025 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
November 07, 2025 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
November 06, 2025 | Company Announcements
Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed
November 05, 2025 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
November 04, 2025 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
November 01, 2025 | Press Releases
Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business
October 31, 2025 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
October 31, 2025 | Company Announcements
Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira
October 31, 2025 | Company Announcements
Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox
October 29, 2025 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
October 28, 2025 | Press Releases
Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines
October 21, 2025 | Company Announcements
Consortium consisting of Nordic Capital and Permira lowers the minimum acceptance condition to 66 2/3% in respect of the takeover offer to the shareholders of Bavarian Nordic
October 16, 2025 | Company Announcements
The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira
October 15, 2025 | Company Announcements
Consortium consisting of Nordic Capital and Permira increases offer price and extends offer period until 5 November 2025 in respect of the takeover offer to the shareholders of Bavarian Nordic
October 13, 2025 | Company Announcements
Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira
October 09, 2025 | Company Announcements
Consortium consisting of Nordic Capital and Permira receives final regulatory approval in respect of its takeover offer to the shareholders of Bavarian Nordic
October 07, 2025 | Company Announcements
Bavarian Nordic Reports Positive Topline Data for Mpox/Smallpox Vaccine in Pediatric Population
September 29, 2025 | Company Announcements
Consortium consisting of Nordic Capital and Permira extends offer period until 14 October 2025 and provides update on regulatory approvals in respect of the takeover offer to the shareholders of Bavarian Nordic
September 05, 2025 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise